Close Menu
TechCentralTechCentral

    Subscribe to the newsletter

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    Facebook X (Twitter) YouTube LinkedIn
    WhatsApp Facebook X (Twitter) LinkedIn YouTube
    TechCentralTechCentral
    • News

      War of words erupts over home affairs database fee hike

      24 June 2025

      Don’t expect Starlink in South Africa anytime soon

      24 June 2025

      Finally! Tribunal unpacks why it blocked Vodacom’s Vumatel deal

      24 June 2025

      Samsung to unveil new folding phones at July event

      24 June 2025

      Capital Appreciation banks on payments to offset software slump

      24 June 2025
    • World

      Mira Murati’s Thinking Machines hits $10-billion valuation

      24 June 2025

      Watch | Starship rocket explodes in setback to Musk’s Mars mission

      19 June 2025

      Trump Mobile dials into politics, profit and patriarchy

      17 June 2025

      Samsung plots health data hub to link users and doctors in real time

      17 June 2025

      Beijing’s chip champions blacklisted by Taiwan

      16 June 2025
    • In-depth

      Meta bets $72-billion on AI – and investors love it

      17 June 2025

      MultiChoice may unbundle SuperSport from DStv

      12 June 2025

      Grok promised bias-free chat. Then came the edits

      2 June 2025

      Digital fortress: We go inside JB5, Teraco’s giant new AI-ready data centre

      30 May 2025

      Sam Altman and Jony Ive’s big bet to out-Apple Apple

      22 May 2025
    • TCS

      TechCentral Nexus S0E3: Behind Takealot’s revenue surge

      23 June 2025

      TCS | South Africa’s Sociable wants to make social media social again

      23 June 2025

      TCS+ | AfriGIS’s Helen Hulett on how tech can help resolve South Africa’s water crisis

      18 June 2025

      TechCentral Nexus S0E2: South Africa’s digital battlefield

      16 June 2025

      TechCentral Nexus S0E1: Starlink, BEE and a new leader at Vodacom

      8 June 2025
    • Opinion

      South Africa pioneered drone laws a decade ago – now it must catch up

      17 June 2025

      AI and the future of ICT distribution

      16 June 2025

      Singapore soared – why can’t we? Lessons South Africa refuses to learn

      13 June 2025

      South Africa risks being left behind as stablecoins reshape global finance

      6 June 2025

      Beyond the box: why IT distribution depends on real partnerships

      2 June 2025
    • Company Hubs
      • Africa Data Centres
      • AfriGIS
      • Altron Digital Business
      • Altron Document Solutions
      • Altron Group
      • Arctic Wolf
      • AvertITD
      • Braintree
      • CallMiner
      • CambriLearn
      • CYBER1 Solutions
      • Digicloud Africa
      • Digimune
      • Domains.co.za
      • ESET
      • Euphoria Telecom
      • Incredible Business
      • iONLINE
      • Iris Network Systems
      • LSD Open
      • NEC XON
      • Network Platforms
      • Next DLP
      • Ovations
      • Paracon
      • Paratus
      • Q-KON
      • SevenC
      • SkyWire
      • Solid8 Technologies
      • Telit Cinterion
      • Tenable
      • Vertiv
      • Videri Digital
      • Wipro
      • Workday
    • Sections
      • AI and machine learning
      • Banking
      • Broadcasting and Media
      • Cloud services
      • Contact centres and CX
      • Cryptocurrencies
      • Education and skills
      • Electronics and hardware
      • Energy and sustainability
      • Enterprise software
      • Fintech
      • Information security
      • Internet and connectivity
      • Internet of Things
      • Investment
      • IT services
      • Lifestyle
      • Motoring
      • Public sector
      • Retail and e-commerce
      • Science
      • SMEs and start-ups
      • Social media
      • Talent and leadership
      • Telecoms
    • Events
    • Advertise
    TechCentralTechCentral
    Home » News » South Africa falling behind in race to secure Covid-19 vaccines

    South Africa falling behind in race to secure Covid-19 vaccines

    By Agency Staff3 December 2020
    Twitter LinkedIn Facebook WhatsApp Email Telegram Copy Link
    News Alerts
    WhatsApp
    Image: Daniel Schludi

     

    South Africa, the country with the worst confirmed coronavirus outbreak in Africa, is yet to provide clarity on how it plans to order vaccines, even as the global race to secure inoculations accelerates.

    South Africa is hosting three trials, including for Johnson & Johnson and a partnership between AstraZeneca and the University of Oxford, yet hasn’t announced a firm strategy to immunise a population that’s bracing for a potential resurgence of the pandemic. Almost 22 000 people have died of Covid-19 in the nation, the 14th highest worldwide.

    South Africa did confirm last week that it plans to sign up to Covax, a global initiative that strives to ensure that poorer countries have access to shots. The national treasury paid R500-million toward the programme and will need to find a further R4.5-billion to move to “the front of the queue”, finance minister Tito Mboweni said in an interview.

    What worries me about government is the clear lack of communication. We’re all sitting here terrified, not knowing if we get the vaccine

    Yet that proposal will initially provide doses for just 3% of South Africa’s population of about 59 million, according to Anban Pillay, deputy director-general of the department of health, or 10% over the longer term. The government has said that frontline healthcare workers and the elderly will be given priority, meaning advance-purchase agreements with pharmaceutical companies will be needed to protect the wider community.

    “What worries me about government is the clear lack of communication,” Francois Venter, a professor of medicine at the University of the Witwatersrand and a former member of the ministerial advisory council on the virus, said in an interview. “We’re all sitting here terrified, not knowing if we get the vaccine.”

    Critical time

    The lack of progress comes at a critical time for South Africa, which is seeing a new surge in coronavirus cases in some provinces just as millions of people prepare to travel to home towns and holiday destinations. A protracted lockdown starting in March hobbled the economy and caused millions of job losses, and a need for further restrictions is likely to undermine President Cyril Ramaphosa’s focus on revival.

    While Pillay said the government has been talking to “a number of manufacturers” about bilateral deals, other countries have already put pen to paper. The UK has secured access to 357 million doses from seven different developers. Brazil has agreed to buy a total of 186 million from a combination of AstraZeneca and Covax.

    In Africa, Botswana and Namibia agreed in November to procure sufficient vaccines from Covax for 20% of their populations of about two million people each. Rwanda plans to raise US$15-million for its first batch of shots, finance minister Uzziel Ndagijimana said last week.

    Image: Daniel Schludi

    Lwazi Manzi, a spokeswoman for health minister Zweli Mkhize, said the minister will make an announcement “in due course”. Barry Schoub, the chairman of the ministerial advisory council, said he can’t comment on plans to pre-order vaccines.

    Pfizer, co-maker of the vaccine approved by the UK this week, said it has started engagements with the South African government, without giving further detail.

    Aspen Pharmacare Holdings, Africa’s biggest drugmaker, signed a deal last month to manufacture about a third of the billion doses J&J hopes to produce next year in a South African factory. Half of the total will be destined for emerging markets under the Covax programme, according to Stavros Nicolaou, Aspen’s senior executive for trade.

    J&J has offered the shots to South Africa at not-for-profit prices, according to Glenda Gray, CEO of the South African Medical Research Council and co-chair of the local arm of the company’s trial.

    South Africa should be “in a favourable position to start negotiations with manufacturers”, Shabir Madhi, a professor of vaccinology at the University of the Witwatersrand and lead researcher on the country’s leg of the Oxford trial, said by text message. “However, government needs to engage with the manufacturers. I’ve no idea where government is with such negotiations.”  — Reported by Pauline Bax and Antony Sguazzin, (c) 2020 Bloomberg LP



    Anban Pillay Aspen Pharmacare AstraZeneca Covax Francois Venter Glenda Gray Johnson & Johnson South African Medical Research Council Tito Mboweni top
    Subscribe to TechCentral Subscribe to TechCentral
    Share. Facebook Twitter LinkedIn WhatsApp Telegram Email Copy Link
    Previous ArticleCISO Africa: Live online event shines light on mission-critical security objectives
    Next Article Telkom Pay WhatsApp wallet fees revealed

    Related Posts

    Can South Africa quit its deadly coal habit?

    7 March 2025

    South Africa to probe deaths caused by Eskom pollution

    29 February 2024

    Founders Factory secures R2.1-billion to fund start-ups

    14 August 2023
    Company News

    Communication costs exploding? Telviva has a fix for UK-SA teams

    24 June 2025

    Section 18A deductions and BEE points – a strategic choice for business compliance in 2025

    24 June 2025

    Huawei Watch Fit 4 Series: beauty, brains and a battery that won’t quit

    24 June 2025
    Opinion

    South Africa pioneered drone laws a decade ago – now it must catch up

    17 June 2025

    AI and the future of ICT distribution

    16 June 2025

    Singapore soared – why can’t we? Lessons South Africa refuses to learn

    13 June 2025

    Subscribe to Updates

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    © 2009 - 2025 NewsCentral Media

    Type above and press Enter to search. Press Esc to cancel.